Jiangsu Yangdian Science & Technology Co Ltd
SZSE:301012
Balance Sheet
Balance Sheet Decomposition
Jiangsu Yangdian Science & Technology Co Ltd
Jiangsu Yangdian Science & Technology Co Ltd
Balance Sheet
Jiangsu Yangdian Science & Technology Co Ltd
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
8
|
37
|
43
|
73
|
35
|
331
|
112
|
|
| Cash |
0
|
0
|
0
|
73
|
35
|
331
|
112
|
|
| Cash Equivalents |
8
|
37
|
43
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
110
|
|
| Total Receivables |
376
|
357
|
363
|
444
|
317
|
476
|
720
|
|
| Accounts Receivables |
334
|
284
|
314
|
395
|
276
|
439
|
614
|
|
| Other Receivables |
42
|
73
|
49
|
49
|
41
|
38
|
107
|
|
| Inventory |
134
|
111
|
75
|
178
|
356
|
293
|
321
|
|
| Other Current Assets |
14
|
41
|
10
|
30
|
17
|
4
|
104
|
|
| Total Current Assets |
531
|
546
|
491
|
725
|
725
|
1 104
|
1 367
|
|
| PP&E Net |
79
|
59
|
71
|
95
|
156
|
216
|
234
|
|
| PP&E Gross |
79
|
59
|
71
|
95
|
156
|
216
|
234
|
|
| Accumulated Depreciation |
43
|
31
|
38
|
44
|
53
|
67
|
86
|
|
| Intangible Assets |
32
|
25
|
25
|
24
|
45
|
44
|
42
|
|
| Note Receivable |
0
|
0
|
0
|
3
|
7
|
19
|
25
|
|
| Other Long-Term Assets |
4
|
5
|
5
|
8
|
17
|
16
|
19
|
|
| Total Assets |
646
N/A
|
635
-2%
|
592
-7%
|
856
+45%
|
949
+11%
|
1 400
+47%
|
1 687
+21%
|
|
| Liabilities | ||||||||
| Accounts Payable |
205
|
124
|
74
|
102
|
64
|
110
|
154
|
|
| Accrued Liabilities |
11
|
4
|
8
|
4
|
8
|
5
|
7
|
|
| Short-Term Debt |
140
|
125
|
121
|
176
|
252
|
146
|
348
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Current Liabilities |
13
|
27
|
5
|
9
|
2
|
2
|
5
|
|
| Total Current Liabilities |
369
|
280
|
208
|
290
|
325
|
262
|
516
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
7
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Minority Interest |
23
|
23
|
0
|
0
|
0
|
7
|
7
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
4
|
5
|
|
| Total Liabilities |
392
N/A
|
303
-23%
|
208
-31%
|
291
+40%
|
327
+12%
|
274
-16%
|
535
+95%
|
|
| Equity | ||||||||
| Common Stock |
20
|
63
|
63
|
84
|
84
|
142
|
142
|
|
| Retained Earnings |
234
|
27
|
76
|
128
|
185
|
184
|
240
|
|
| Additional Paid In Capital |
0
|
243
|
245
|
353
|
353
|
799
|
799
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
30
|
|
| Total Equity |
254
N/A
|
333
+31%
|
384
+16%
|
565
+47%
|
622
+10%
|
1 126
+81%
|
1 152
+2%
|
|
| Total Liabilities & Equity |
646
N/A
|
635
-2%
|
592
-7%
|
856
+45%
|
949
+11%
|
1 400
+47%
|
1 687
+21%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
165
|
165
|
165
|
165
|
165
|
199
|
197
|
|